Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 6 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse, and diversion seen with opioids, or the opioid-induced side effects, including potentially life-threatening respiratory depression.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Neumentum

Joseph V. Pergolizzi

Joseph M. Scavone

Mark Kociscin

Frank Diana

Sarah Faust

Robert B. Raffa

The board of directors at Neumentum have a wide range of experience in the pharmaceutical industry. They have worked at companies such as Jazz Pharmaceuticals, Millennium Health, and Purdue Pharma. Their educational backgrounds are in health administration and pharmacy.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Neumentum

Leadership Team

CEO and Executive Team